The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Canadian research scientist Cori Lausen is studying probiotics as a treatment for white-nose syndrome, which is caused by a ...

The FDA has approved Tezspire (tezepelumab-ekko) for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with ...

A recent study suggests that two existing drugs, empagliflozin and an experimental insulin nasal spray, may help enhance ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The FDA has approved Tezspire (tezepelumab-ekko), a biologic therapy by Amgen and AstraZeneca, as an add-on maintenance ...

Amgen and AstraZeneca’s Tezspire (tezepelumab-ekko) gains FDA approval as an add-on maintenance therapy for patients aged 12 and older with inadequately controlled chronic rhinosinusitis with nasal ...

Investing.com -- AstraZeneca and Amgen have received European Union approval for Tezspire as an add-on therapy for adults ...

Natural remedies like allergen avoidance and nasal rinses can ease symptoms of seasonal allergies. Therapies like acupuncture may also be helpful.

The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...